Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 14 results.
User Information
Export Records
  1. 1.   Farnesyltransferase-Mediated Delivery of a Covalent Inhibitor Overcomes Alternative Prenylation to Mislocalize K-Ras
  2. Novotny, Chris J.; Hamilton, Gregory L.; McCormick, Frank; Shokat, Kevan M.
  3. ACS CHEMICAL BIOLOGY. 2017, Jul; 12(7): 1956-1962.
  1. 2.   The B-Raf Status of Tumor Cells May Be a Significant Determinant of Both Antitumor and Anti-Angiogenic Effects of Pazopanib in Xenograft Tumor Models
  2. Gril, B.; Palmieri, D.; Qian, Y.; Anwar, T.; Ileva, L.; Bernardo, M.; Choyke, P.; Liewehr, D. J.; Steinberg, S. M.; Steeg, P. S.
  3. Plos One. 2011, Oct; 6(10): 11.
  1. 3.   Role of IKK alpha in skin squamous cell carcinomas
  2. Park, E. M.; Liu, B. G.; Xia, X. J.; Zhu, F.; Jami, W. B.; Hu, Y. L.
  3. Future Oncology. 2011, Jan; 7(1): 123-134.
  1. 4.   IKK alpha is required to maintain skin homeostasis and prevent skin cancer
  2. Liu, B. G.; Xia, X. J.; Zhu, F.; Park, E.; Carbajal, S.; Kiguchi, K.; DiGiovanni, J.; Fischer, S. M.; Hu, Y. L.
  3. Cancer Cell. 2008 14(3): 212-225.
  1. 5.   DNA damage, superoxide, and mutant K-ras in human lung adenocarcinoma cells
  2. Romanowska, M.; Maciag, A.; Smith, A. L.; Fields, J. R.; Fornwald, L. W.; Kikawa, K. D.; Kasprzak, K. S.; Anderson, L. M.
  3. Free Radical Biology and Medicine. 2007, Oct; 43(8): 1145-1155.
  1. 6.   Genetic ablation of CCAAT/Enhancer binding protein alpha in epidermis reveals its role in suppression of epithelial tumorigenesis
  2. Loomis, K. D.; Zhu, S.; Yoon, K.; Johnson, P. F.; Smart, R. C.
  3. Cancer Research. 2007, Jul; 67(14): 6768-6776.
  1. 7.   Reactive oxygen species and lung tumorigenesis by mutant K-ras: A working hypothesis
  2. Maciag, A.; Anderson, L. M.
  3. Experimental Lung Research. 2005, JAN-FEB; 31(1): 83-104.
  1. 8.   CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling
  2. Zhu, S. Y.; Yoon, K.; Sterneck, E.; Johnson, P. F.; Smart, R. C.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2002 99(1): 207-212.
  1. 9.   Transcriptional repressor ERF is a Ras/mitogen-activated protein kinase target that regulates cellular proliferation
  2. Le Gallic, L.; Sgouras, D.; Beal, G.; Mavrothalassitis, G.
  3. Molecular and Cellular Biology. 1999 19(6): 4121-4133.
  1. 10.   Cell cycle-related differences in susceptibility of NIH/3T3 cells to ribonucleases
  2. Smith, M. R.; Newton, D. L.; Mikulski, S. M.; Rybak, S. M.
  3. Experimental Cell Research. 1999 247(1): 220-232.
  1. 11.   Identification of Residues in the Cysteine-Rich Domain of Raf-1 That Control Ras Binding and Raf-1 Activity
  2. Winkler, D. G.; Cutler, R. E.; Drugan, J. K.; Campbell, S.; Morrison, D. K.; Cooper, J. A.
  3. Journal of Biological Chemistry. 1998 273(34): 21578-21584.
  1. 12.   Autoregulation of the Raf-1 Serine/Threonine Kinase
  2. Cutler, R. E.; Stephens, R. M.; Saracino, M. R.; Morrison, D. K.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1998 95(16): 9214-9219.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel